Latus Bio

Latus Bio is a clinical-stage gene therapy company engineering novel adeno-associated virus (AAV) capsids to deliver genetic medicines to precise cell types in the central nervous system and peripheral tissues. The company screens tens of millions of novel capsid variants to build a proprietary database of tissue-targeting "delivery zip codes," pairing engineered capsids with optimized routes of administration so therapeutics reach the intended tissue at a fraction of conventional doses and with minimal off-tissue biodistribution. Its lead programs are LTS-201 for Huntington's disease (AAV.DB-3 capsid) and LTS-101 for CLN2 disease, spanning CNS and ocular delivery (AAV.Ep+ capsid). Latus Bio operates offices and laboratories in Philadelphia, Pennsylvania and in Boston's Seaport district, and is backed by DCVC Bio, 8VC, BioAdvance, Samsung Venture Investment, and KDB. Latus Bio is catalogued in the API Evangelist network as a life-sciences company; it publishes no public developer platform, API, or SDK surface at this time.

Latus Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Gene Therapy, Life Sciences, and Genomics.

Latus Bio’s developer surface includes product news and 9 more developer resources.

🌐 Visit website 📡 Source on GitHub

13.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyGene TherapyLife SciencesGenomicsNeuroscienceDrug DevelopmentHealthcare

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 13.9/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/latus-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

ContactUs

ContactUs

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 3

The organization behind the API

Website

Website

About

About

News

News

Other 2

Properties that don't map to a standard resource type

Technology

Technology

Products

Products

Source (apis.yml)

aid: latus-bio
name: Latus Bio
description: Latus Bio is a clinical-stage gene therapy company engineering novel adeno-associated virus (AAV) capsids to
  deliver genetic medicines to precise cell types in the central nervous system and peripheral tissues. The company screens
  tens of millions of novel capsid variants to build a proprietary database of tissue-targeting "delivery zip codes," pairing
  engineered capsids with optimized routes of administration so therapeutics reach the intended tissue at a fraction of conventional
  doses and with minimal off-tissue biodistribution. Its lead programs are LTS-201 for Huntington's disease (AAV.DB-3 capsid)
  and LTS-101 for CLN2 disease, spanning CNS and ocular delivery (AAV.Ep+ capsid). Latus Bio operates offices and laboratories
  in Philadelphia, Pennsylvania and in Boston's Seaport district, and is backed by DCVC Bio, 8VC, BioAdvance, Samsung Venture
  Investment, and KDB. Latus Bio is catalogued in the API Evangelist network as a life-sciences company; it publishes no public
  developer platform, API, or SDK surface at this time.
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://cdn.prod.website-files.com/6627bc4f363f9254dfeb7cd5/6811bb94bfa33f80970b4e88_home-img.png
url: https://raw.githubusercontent.com/api-evangelist/latus-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- 8vc
- dcvc
x-tier: profile
x-tier-reason: no-public-api-surface
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Gene Therapy
- Life Sciences
- Genomics
- Neuroscience
- Drug Development
- Healthcare
apis: []
common:
- type: Website
  url: https://www.latusbio.com/
- type: About
  url: https://www.latusbio.com/about-us
- type: Technology
  url: https://www.latusbio.com/our-approach
- type: Products
  url: https://www.latusbio.com/our-pipeline
- type: News
  url: https://www.latusbio.com/news-publications
- type: ContactUs
  url: https://www.latusbio.com/contact-us
- type: PrivacyPolicy
  url: https://www.latusbio.com/privacy-policy
- type: TermsOfService
  url: https://www.latusbio.com/terms-of-use
- type: LLMsTxt
  url: llms/latus-bio-llms.txt
- type: DomainSecurity
  url: security/latus-bio-domain-security.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence